NCT02221531View on ClinicalTrials.gov

Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN

PHASE4CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Complications; Cesarean SectionAnesthesia; Reaction
Interventions
DRUG

Carbetocin Short-infusion

Short-infusion of Carbetocin 100 microgram as compared to bolus application of Carbetocin 100 microgram (double dummy method)

DRUG

Carbetocin Bolus application

Carbetocin 100 microgram given intravenously as a bolus application over about 15 seconds

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
collaborator

Obstetric Anaesthetists' Association United Kingdom

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT02221531 - Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN | Biotech Hunter | Biotech Hunter